| Chondroitin sulfate glycosaminoglycan scaffolds for cell and recombinant protein-based bone regeneration S Andrews, A Cheng, H Stevens, MT Logun, R Webb, E Jordan, B Xia, ... Stem cells translational medicine 8 (6), 575-585, 2019 | 46 | 2019 |
| Microfluidics in malignant glioma research and precision medicine M Logun, W Zhao, L Mao, L Karumbaiah Advanced biosystems 2 (5), 1700221, 2018 | 36 | 2018 |
| Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors Y Yin, JL Rodriguez, N Li, R Thokala, MLP Nasrallah, L Hu, L Zhang, ... Molecular Therapy 30 (7), 2537-2553, 2022 | 35 | 2022 |
| Cortical Transplantation of Brain‐Mimetic Glycosaminoglycan Scaffolds and Neural Progenitor Cells Promotes Vascular Regeneration and Functional Recovery after Ischemic Stroke … MR McCrary, K Jesson, ZZ Wei, M Logun, C Lenear, S Tan, X Gu, ... Advanced healthcare materials 9 (5), 1900285, 2020 | 35 | 2020 |
| Glioma cell invasion is significantly enhanced in composite hydrogel matrices composed of chondroitin 4-and 4, 6-sulfated glycosaminoglycans MT Logun, NS Bisel, EA Tanasse, W Zhao, B Gunasekera, L Mao, ... Journal of materials chemistry B 4 (36), 6052-6064, 2016 | 35 | 2016 |
| Label-free ferrohydrodynamic separation of exosome-like nanoparticles Y Liu, W Zhao, R Cheng, M Logun, M del Mar Zayas-Viera, L Karumbaiah, ... Lab on a Chip 20 (17), 3187-3201, 2020 | 25 | 2020 |
| Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion MT Logun, KE Wynens, G Simchick, W Zhao, L Mao, Q Zhao, S Mukherjee, ... The FASEB journal 33 (11), 11973, 2019 | 25 | 2019 |
| Expanding hydrophobically modified chitosan foam for internal surgical hemostasis: Safety evaluation in a murine model MT Logun, MB Dowling, SR Raghavan, ML Wallace, C Schmiedt, S Stice, ... journal of surgical research 239, 269-277, 2019 | 24 | 2019 |
| 3, 4-Methylenedioxymethamphetamine increases affiliative behaviors in squirrel monkeys in a serotonin 2A receptor-dependent manner EG Pitts, AR Minerva, EB Chandler, JN Kohn, MT Logun, A Sulima, ... Neuropsychopharmacology 42 (10), 1962-1971, 2017 | 21 | 2017 |
| Fully synthetic heparan sulfate-based neural tissue construct that maintains the undifferentiated state of neural stem cells P Chopra, MT Logun, EM White, W Lu, J Locklin, L Karumbaiah, ... ACS chemical biology 14 (9), 1921-1929, 2019 | 12 | 2019 |
| Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results SJ Bagley, M Logun, JA Fraietta, X Wang, AS Desai, LJ Bagley, ... Nature Medicine, 1-10, 2024 | 7 | 2024 |
| Glycosaminoglycan scaffolding and neural progenitor cell transplantation promotes regenerative immunomodulation in the mouse ischemic brain MR McCrary, MQ Jiang, K Jesson, X Gu, MT Logun, A Wu, N Gonsalves, ... Experimental neurology 357, 114177, 2022 | 7 | 2022 |
| Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial SJ Bagley, ZA Binder, L Lamrani, E Marinari, AS Desai, MLP Nasrallah, ... Nature Cancer, 1-15, 2024 | 3 | 2024 |
| Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products M Logun, MB Colonna, KP Mueller, D Ventarapragada, R Rodier, ... Cytotherapy 25 (6), 670-682, 2023 | 2 | 2023 |
| Phase I study of repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab in patients with newly diagnosed, MGMT-unmethylated glioblastoma SJ Bagley, ZA Binder, AS Desai, MP Nasrallah, E Maloney, S Brem, ... | 1 | 2023 |
| Kinetics and potency of T cell and CAR-T cell mediated cytolysis of glioma stem cells HB Hayes, MT Logun, SA Chvatal, K Mueller, N Piscopo, A Das, K Saha, ... Cancer Research 81 (13_Supplement), 1552-1552, 2021 | 1 | 2021 |
| FOXO1 is a master regulator of memory programming in CAR T cells AE Doan, KP Mueller, AY Chen, GT Rouin, Y Chen, B Daniel, J Lattin, ... Nature, 1-8, 2024 | | 2024 |
| Armored Bicistronic CAR T Cells with Dominant-negative TGF-β Receptor II to Overcome Resistance in Glioblastoma. N Li, JL Rodriguez, Y Yin, MT Logun, S Yu, KA Hicks, VI Zhang, L Zhang, ... bioRxiv, 2024.02. 26.582107, 2024 | | 2024 |
| REPEATED PERIPHERAL INFUSIONS OF ANTI-EGFRVIII CAR T CELLS IN COMBINATION WITH PEMBROLIZUMAB REMODELS THE TUMOR MICROENVIRONMENT IN DE NOVO GLIOBLASTOMA Z Binder, SJ Bagley, L Lamrani, E Marinari, A Desai, MLP Nasrallah, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| CTIM-40. EARLY RADIOGRAPHIC RESPONSE AND ENGRAFTMENT OF PHASE I FIRST-IN-HUMAN BICISTRONIC CAR T CELLS CORRELATE WITH REAL-TIME AUTOLOGOUS GBM ORGANOID CYTOLYSIS M Logun, SJ Bagley, X Wang, D Zhang, Y Sun, G Ming, A Nabavizadeh, ... Neuro-Oncology 25 (Supplement_5), v72-v72, 2023 | | 2023 |
Zev A. BinderUniversity of PennsylvaniaVerified email at pennmedicine.upenn.edu
